Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells

Surgery

Volumn 138, Issue 6, 2005, Pages 979-985

  Shen, Wen T ^b   Wong, Ted S ^b   Chung, Woong Youn ^b   Wong, Mariwil G ^b   Kebebew, Electron ^b   Duh, Quan Yang ^b   Clark, Orlo H ^a   Shaha, Ashok R ^b   Monchik, John M ^b   Weigel, Ronald J ^b   Chen, Herbert ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY FOLLICLE CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THYROID CARCINOMA; UPREGULATION;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; HISTONE DEACETYLASES; HUMANS; RNA, MESSENGER; SYMPORTERS; THYROGLOBULIN; THYROID NEOPLASMS; VALPROIC ACID;

EID: 29144445219     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.09.019     Document Type: Article

References (20)

1. J.W. Park, and O.H. Clark Redifferentiation therapy for thyroid cancer Surg Clin North Am 84 2004 921 943
2. M. Braga-Basaria, and M.D. Ringel Beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer J Clin Endocrinol Metab 88 2003 1947 1960
3. P. Marks, R.A. Rifkind, V.M. Richon, R. Breslow, T. Miller, and W.K. Kelly Histone deacetylases and cancer: causes and therapies Nat Rev Cancer 1 2001 194 202
4. R. Zarnegar, L. Brunaud, H. Kanauchi, M. Wong, M. Fung, and D. Ginzinger Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor Surgery 132 2002 984 990
5. M. Kitazono, R. Robey, Z. Zhan, N.J. Sarlis, M.C. Skarulis, and T. Aikou Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells J Clin Endocrinol Metab 86 2001 3430 3435
6. C.J. Phiel, F. Zhang, E.Y. Huang, M.G. Guenther, M.A. Lazar, and P.S. Klein Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J Biol Chem 276 2001 36734 36741
7. M. Gottlicher, S. Minucci, P. Zhu, O.H. Kramer, A. Schimpf, and S. Giavara Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells EMBO J 20 2001 6969 6978
8. N. Gurvich, O.M. Tsygankova, J.L. Meinkoth, and P.S. Klein Histone deacetylase is a target of valproic acid-mediated cellular differentiation Cancer Res 64 2004 1079 1086
9. M. Gottlicher Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases Ann Hematol 83 suppl 2004 S91 S92
10. K. Camphausen, D. Cerna, T. Scott, M. Sproull, W.E. Burgan, and M.A. Cerra Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid Int J Cancer 114 2005 380 386
11. A. Kuendgen, C. Strupp, M. Aivado, A. Bernhardt, B. Hildebrandt, and R. Haas Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid Blood 104 2004 1266 1269
12. S. Sakajiri, T. Kumagai, N. Kawamata, T. Saitoh, J.W. Said, and H.P. Koeffler Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines Exp Hematol 33 2005 53 61
13. N. Takai, J.C. Desmond, T. Kumagai, D. Gui, J.W. Said, and S. Whittaker Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells Clin Cancer Res 10 2004 1141 1149
14. N. Takai, N. Kawamata, D. Gui, J.W. Said, I. Miyakawa, and H.P. Koeffler Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis Cancer 101 2004 2760 2770
15. P. Thelen, S. Schweyer, B. Hemmerlein, W. Wuttke, F. Seseke, and R.H. Ringert Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells Int J Oncol 24 2004 25 31
16. N. Fortunati, M.G. Catalano, K. Arena, E. Brignardello, A. Piovesan, and G. Boccuzzi Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells J Clin Endocrinol Metab 89 2004 1006 1009
17. M.G. Catalano, N. Fortunati, M. Pugliese, L. Costantino, R. Poli, and O. Bosco Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells J Clin Endocrinol Metab 89 2004 1383 1389
18. D.G. Ginzinger Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream Exp Hematol 30 2002 503 512
19. W.T. Shen, M.G. Wong, E. Kebebew, Q.Y. Duh, and O.H. Clark Induction of apoptosis in human follicular thyroid cancer cells by the histone deacetylase inhibitors TSA and FK228 J Am Coll Surg 199 suppl 2004 86
20. S. Cory, D.C. Huang, and J.M. Adams The Bcl-2 family: roles in cell survival and oncogenesis Oncogene 22 2003 8590 8607